We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Phase Two of ISPE Pilot to Continue, Despite FDA’s Quality Metrics Guidance
Phase Two of ISPE Pilot to Continue, Despite FDA’s Quality Metrics Guidance
The second phase of ISPE’s quality metrics pilot program — which kicked off this month — will continue as planned, despite differences in its metrics and the quality data the FDA plans to collect, says the co-chair of ISPE’s quality metrics team.